Alexandria Real Estate Equities Files 8-K

TL;DR

ARE filed an 8-K on 10/29/25, standard disclosure, check for material info.

AI Summary

Alexandria Real Estate Equities, Inc. filed an 8-K on October 29, 2025, to report information under Regulation FD. The filing does not contain specific financial transactions or material events beyond the standard reporting requirement for the date.

Why It Matters

This 8-K filing indicates Alexandria Real Estate Equities, Inc. is making a regulatory disclosure. Investors should review the filing for any specific material events or information that may impact the company's stock.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for Regulation FD disclosure and does not appear to contain any new material information or significant events.

Key Numbers

• 1-12993 — SEC File Number (Identifies the company's filing with the SEC.)
• 95-4502084 — I.R.S. Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Alexandria Real Estate Equities, Inc. (company) — Registrant
• October 29, 2025 (date) — Date of Report
• Maryland (jurisdiction) — State of Incorporation
• 26 North Euclid Avenue, Pasadena, California 91101 (address) — Principal Executive Offices

FAQ

Key Financial Figures

• $6.25 — mber 31, 2026 to be within the range of $6.25 to $6.85. There can be no assurance t
• $6.85 — 2026 to be within the range of $6.25 to $6.85. There can be no assurance that actua
• $29.0 million — ental revenue aggregating approximately $29.0 million and had a weighted-average lease expira
• $81 m — 6 and annual rental revenue aggregating $81 million, which are expected to become vac
• $4.2 billion — lized interest – There is approximately $4.2 billion of average real estate basis capitalize
• $32 million — average realized gains of approximately $32 million per quarter for the nine months ended S
• $49 m — dministrative expenses of approximately $49 million, or 29%, during the year ending D
• $1.0 billion — sale agreement negotiations aggregated $1.0 billion. We expect these dispositions to close
• $1.75 billion — be similar or slightly higher than the $1.75 billion midpoint of our guidance range for 2025

Filing Documents

• are-20251029.htm (8-K) — 45KB
• 0001035443-25-000202.txt ( ) — 164KB
• are-20251029.xsd (EX-101.SCH) — 2KB
• are-20251029_lab.xml (EX-101.LAB) — 21KB
• are-20251029_pre.xml (EX-101.PRE) — 12KB
• are-20251029_htm.xml (XML) — 3KB

01. Regulation FD

Item 7.01. Regulation FD Based on our current view of market conditions and in consideration of the factors included in the "Summary of Key Items that May Impact 2026 Results" section of our most recent quarterly report on Form 10-Q, as reiterated below, we expect the midpoint of our range for funds from operations per share – diluted, as adjusted for the year ending December 31, 2026 to be within the range of $6.25 to $6.85. There can be no assurance that actual amounts will not be materially higher or lower than these expectations. Our estimate is subject to a number of variables and uncertainties, including actions and changes in policy by the current U.S. administration related to the regulatory environment, life science funding, the U.S. Food and Drug Administration and National Institutes of Health, trade, and other areas as more fully discussed in our most recently filed quarterly report on Form 10-Q. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q. Summary of Key Items That May Impact 2026 Results We expect to introduce additional 2026 guidance on December 3, 2025 at our Investor Day. As disclosed in the Form 8-K furnished on October 27, 2025 and Form 10-Q for the three and nine months ended September 30, 2025, the following is an initial summary of key items that are expected to impact 2026 results: Core operations – Slower demand across the life science sector and increased supply for life science real estate could negatively impact future occupancy. Additional considerations include the following: Same property net operating income decrease for 3Q25 compared to 3Q24 of 6.0% reflects a decline relative to the first half of 2025. Operating occupancy has decr

Forward-looking Statements

Forward-looking Statements This current report on Form 8-K contains forward-looking non-GAAP financial measures, including funds from operations, per share – diluted, as adjusted. We do not provide guidance for the most comparable GAAP financial measure or a reconciliation of the forward-looking non-GAAP financial measure of FFO, as adjusted because we are unable to reasonably predict, without unreasonable efforts, certain items that would be contained in the comparable GAAP measure, including items that are not indicative of our ongoing operations, including, without limitation, unrealized gains or losses on non-real estate investments, potential impairments of real estate assets, and gains or losses on the sales of real estate. These items are uncertain, depend on various factors, and could have a material impact on our GAAP results for the guidance periods. This current report on Form 8-K also contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our projected 2026 funds from operations per share, as adjusted, projected net operating income, and our projected sources and uses of capital. You can identify the forward-looking statements by their use of forward-looking words, such as "forecast," "guidance," "goals," "projects," "estimates," "anticipates," "believes," "expects," "intends," "may," "plans," "seeks," "should," "targets," or "will," or the negative of those words or similar words. These forward-looking statements are based on our current expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. There can be no assurance that actual results will not be materially higher or lowe

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALEXANDRIA REAL ESTATE EQUITIES, INC. Date: October 29, 2025 By: /s/ Marc E. Binda Marc E. Binda Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR